Sarcomas and DDR-Inhibition; a Combined Modality Study

NCT05116254 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Endpoint has been reached.

Conditions

Soft Tissue Sarcoma Adult

Interventions

COMBINATION_PRODUCT: AZD1390 + radiotherapy
COMBINATION_PRODUCT: AZD1390 + durvlaumab + radiotherapy

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]
[object Object]